Search Results 821-830 of 8463 for 78%
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Go to page 7878 · NextNext Page . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees · Site Map · About This Site ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may ...
In the present study we aim at validating the computation of FFRangio values from the angiogram by comparing them to measured wire-based FFR values, in a larger ...
The purpose of the research is to determine whether repairing a tricuspid valve (TV) in patients with mild to moderate tricuspid regurgitation (TR), at the time ...
About this study. TARGET-NASH is a longitudinal observational cohort study of patients being managed for NAFLD or NASH in usual clinical practice.
Go to page 7878 · Go to page 7979 · Go to page 8080 · Go to page 8181 · Go to page 8282 · NextNext Page . Mayo Clinic Footer. Request Appointment · Give Now ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.